Publications by authors named "Valerio Maria Carrozzo"
Pharmaceutics
October 2024
Article Synopsis
- Interstitial lung diseases (ILDs) involve a wide range of over 200 conditions that need personalized treatment approaches.
- Antifibrotic drugs like nintedanib and pirfenidone have significantly improved treatment options for idiopathic pulmonary fibrosis (IPF) and some other forms of progressive pulmonary fibrosis.
- Despite advancements, treatments can have significant side effects; hence, research is being conducted on inhalation methods to achieve higher concentrations of medication directly in the lungs while reducing overall side effects.
